ExodusPoint Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-93,170
| Closed | -$1.87M | – | 1698 |
|
|
2023
Q3 | $1.87M | Sell |
93,170
-65,660
| -41% | -$1.32M | 0.02% | 663 |
|
|
2023
Q2 | $4.27M | Buy |
+158,830
| New | +$4.27M | 0.03% | 444 |
|
|
2023
Q1 | – | Sell |
-73,742
| Closed | -$3.76M | – | 1853 |
|
|
2022
Q4 | $3.76M | Buy |
73,742
+26,590
| +56% | +$1.36M | 0.05% | 413 |
|
|
2022
Q3 | $3.86M | Buy |
47,152
+4,086
| +9% | +$335K | 0.05% | 472 |
|
|
2022
Q2 | $2.91M | Buy |
43,066
+41,767
| +3,215% | +$2.83M | 0.04% | 587 |
|
|
2022
Q1 | $144K | Sell |
1,299
-5,961
| -82% | -$661K | ﹤0.01% | 1905 |
|
|
2021
Q4 | $700K | Buy |
7,260
+5,265
| +264% | +$508K | 0.01% | 1210 |
|
|
2021
Q3 | $174K | Buy |
1,995
+187
| +10% | +$16.3K | ﹤0.01% | 1759 |
|
|
2021
Q2 | $280K | Buy |
1,808
+81
| +5% | +$12.5K | ﹤0.01% | 1710 |
|
|
2021
Q1 | $273K | Buy |
+1,727
| New | +$273K | ﹤0.01% | 1685 |
|
|
2020
Q4 | – | Sell |
-1,513
| Closed | -$331K | – | 2099 |
|
|
2020
Q3 | $331K | Buy |
+1,513
| New | +$331K | 0.01% | 1177 |
|
|
2020
Q2 | – | Sell |
-1,917
| Closed | -$552K | – | 1872 |
|
|
2020
Q1 | $552K | Buy |
+1,917
| New | +$552K | 0.03% | 411 |
|
|
2019
Q4 | – | Sell |
-6,600
| Closed | -$952K | – | 1657 |
|
|
2019
Q3 | $952K | Buy |
6,600
+4,880
| +284% | +$704K | 0.03% | 377 |
|
|
2019
Q2 | $155K | Buy |
+1,720
| New | +$155K | 0.01% | 945 |
|